MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer

Larynx cancer organ preservation treatments with chemo and radiotherapy have substantially improved laryngoesophageal dysfunction-free survival. However, both of them lead to a high incidence of acute and chronic toxicities and a significant number of patients relapse. To date, there is no evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: de Miguel-Luken, María-José, Chaves-Conde, Manuel, de Miguel-Luken, Verónica, Muñoz-Galván, Sandra, López-Guerra, José Luis, Mateos, Juan C., Pachón, Jerónimo, Chinchón, David, Suarez, Vladimir, Carnero, Amancio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494962/
https://www.ncbi.nlm.nih.gov/pubmed/25788275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494962/
https://www.ncbi.nlm.nih.gov/pubmed/25788275

Ejemplares similares